Health spending in Canada was approximately $264 billion in 2019, 30% represents private-sector spending1 One of the main pain points for employers and insurers is the multiple vendors required to cover the spectrum of healthcare services CloudMD delivers one centralized platform that addresses access […]
The news comes days after early-stage data showed Medicago’s plant-based vaccine candidate produced virus-fighting antibodies in all volunteers. Medicago, backed by cigarette maker Philip Morris International, is Canada’s most advanced COVID-19 vaccine project, but lags larger, global rivals. Medicago has said a lower dose of the vaccine will be used for further trials, for which Dynavax Technologies’ adjuvant will not be used as before. …read more […]
(Bloomberg Opinion) — After five states — Arizona, Mississippi, Montana, New Jersey and South Dakota — passed ballot measures for marijuana use last week, the drug will soon be legal in some form for 70% of the U.S. population. A third of the country won’t even need a medical excuse. But that’s not the surprise.What’s more notable is that unlike in the past, all of this happened without much of a public uproar. To be fair, there have been bigger concerns on Americans’ minds these days. But this is the moment that cannabis companies and their investors have been waiting …read more […]
Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) just released its third-quarter report and things are looking bullish. Sales… …read more […]
Online retailers have largely benefited from the COVID-19 pandemic, as individuals staying home use e-commerce platforms like Alibaba, Pinduoduo and JD.com to purchase everything from groceries to electric appliances. Non-GAAP net profit, reported for the first time since the company’s listing in 2018, was 466.4 million yuan compared with a loss of 1.66 billion yuan a year before. “This is a milestone,” said Natalie Wu, internet analyst at Haitong International Securities. …read more […]
Regular readers will know that we love our dividends at Simply Wall St, which is why it’s exciting to see Valero… …read more […]
The International Air Transport Association is calling on governments and airlines worldwide to prepare for a global armada to deliver coronavirus vaccine. …read more […]
* WELL achieved another record quarter for Q3-2020 with revenue of $12,245,735 and record Gross profit(1) of $5,045,440, representing 50% and 75% year-over-year (“YoY”) growth respectively. Coupled with recently completed and announced acquisitions, WELL is currently on a ~$68M annualized revenue run-rate and growing quickly. …read more […]
Experts are urging the American public to continue following public health guidelines, including mask wearing and social distancing. …read more […]
Stock futures were mostly lower Thursday morning, with contracts on the Dow and S&P 500 sliding as optimism over a COVID-19 vaccine moderated further. …read more […]
Regular readers will know that we love our dividends at Simply Wall St, which is why it’s exciting to see Marathon Oil… …read more […]
(Bloomberg) — Fossil Group Inc. shares surged in premarket trading after quarterly revenue beat the watchmaker’s forecasts by a wide margin thanks in part to strong sales in China.Revenue in the third quarter fell 19% to $435 million, Fossil said in a statement. The company had projected a decline of 35% to 45% in the period. The stock gained as much as 32% in early trading Thursday.“We outperformed our topline expectations in the third quarter, reflecting ongoing momentum in our digital channels and strong growth in mainland China, as well as trend improvement in the wholesale channel globally,” Chief Executive …read more […]
A return to organic quarterly growthBOULDER, Colo., Nov. …read more […]
The investors in Infinity Pharmaceuticals, Inc.’s (NASDAQ:INFI) will be rubbing their hands together with glee today… …read more […]
(Bloomberg) — Now it’s Moderna Inc.’s time to be in the spotlight.The same U.S. explosion of Covid-19 cases that helped Pfizer Inc. get results for its vaccine trial earlier this week is helping speed along Moderna’s trial. Moderna said Wednesday its study has accumulated more than 53 infections, allowing a preliminary analysis of the shot’s effectiveness to begin. The shares jumped.Moderna didn’t predict how long it could take an independent monitoring committee to analyze the data, but said the company could get the data to the committee within days. The company said it is still blinded to the data.“Moderna has …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
